Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide

The lawsuits target a range of businesses that allegedly marketed retatrutide products to consumers despite the drug remaining under clinical development.

We haven't written up this one. CNBC World has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at cnbc.com →

More in Health & Medicine

More from Wednesday 12 August →